1. Home
  2. TCOM vs KVUE Comparison

TCOM vs KVUE Comparison

Compare TCOM & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCOM

Trip.com Group Limited

HOLD

Current Price

$70.87

Market Cap

45.9B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.26

Market Cap

39.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCOM
KVUE
Founded
1999
2022
Country
Singapore
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Specialty Chemicals
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.9B
39.9B
IPO Year
2003
2023

Fundamental Metrics

Financial Performance
Metric
TCOM
KVUE
Price
$70.87
$17.26
Analyst Decision
Strong Buy
Buy
Analyst Count
9
13
Target Price
$80.00
$20.31
AVG Volume (30 Days)
2.2M
37.7M
Earning Date
11-17-2025
11-03-2025
Dividend Yield
0.42%
4.79%
EPS Growth
86.40
35.31
EPS
6.25
0.75
Revenue
$8,393,499,281.00
$15,006,000,000.00
Revenue This Year
$18.22
N/A
Revenue Next Year
$13.73
$2.81
P/E Ratio
$11.33
$23.18
Revenue Growth
17.45
N/A
52 Week Low
$51.35
$14.02
52 Week High
$78.65
$25.17

Technical Indicators

Market Signals
Indicator
TCOM
KVUE
Relative Strength Index (RSI) 49.50 58.98
Support Level $69.86 $16.70
Resistance Level $72.07 $17.59
Average True Range (ATR) 1.03 0.30
MACD 0.10 0.02
Stochastic Oscillator 62.74 63.09

Price Performance

Historical Comparison
TCOM
KVUE

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: